We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+19.36%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$561M
Cap. Flow
+$409M
Cap. Flow %
22.52%
Top 10 Hldgs %
16.32%
Holding
823
New
371
Increased
67
Reduced
65
Closed
283

Top Sells

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$29.9M
2
EXAS
Exact Sciences
EXAS
+$12.2M
3
FIVE icon
Five Below
FIVE
+$6.65M
4
KSS icon
Kohl's
KSS
+$6.63M
5
BKS
Barnes & Noble
BKS
+$5.6M

Sector Composition

Rank Sector Weight
1 Healthcare 3.91%
2 Consumer Discretionary 2.56%
3 Technology 1.71%
4 Energy 1.64%
5 Industrials 1.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAG
776
CALL
DELISTED
AMAG Pharmaceuticals
AMAG
-60,000
Closed -$912K
CBL
777
DELISTED
CBL& Associates Properties, Inc.
CBL
-10,000
Closed -$20K
TRQ
778
DELISTED
Turquoise Hill Resources Ltd
TRQ
-32,800
Closed -$541K
TRQ
779
PUT
DELISTED
Turquoise Hill Resources Ltd
TRQ
-37,500
Closed -$619K
AIMT
780
DELISTED
Aimmune Therapeutics
AIMT
-24,800
Closed -$593K
DNR
781
DELISTED
Denbury Resources, Inc.
DNR
-50,000
Closed -$85K
DNR
782
PUT
DELISTED
Denbury Resources, Inc.
DNR
-50,000
Closed -$85K
HCR
783
PUT
DELISTED
Hi-Crush Inc. Common Stock
HCR
-24,000
Closed -$85K
PTLA
784
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-48,600
Closed -$949K
PTLA
785
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-100,000
Closed -$1.95M
PTLA
786
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-127,100
Closed -$2.48M
AKRX
787
DELISTED
Akorn Inc
AKRX
-288,662
Closed -$978K
CORV
788
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
-111,500
Closed -$278K
MLNX
789
PUT
DELISTED
Mellanox Technologies, Ltd.
MLNX
-26,300
Closed -$2.43M
S
790
DELISTED
Sprint Corporation
S
-146,800
Closed -$909K
TLRA
791
DELISTED
Telaria, Inc.
TLRA
-7,820
Closed -$32.6K
AVP
792
DELISTED
Avon Products, Inc.
AVP
-1,400
Closed -$2K
ALDR
793
DELISTED
Alder Biopharmaceuticals
ALDR
-10,000
Closed -$103K
AABA
794
DELISTED
Altaba Inc
AABA
-30,000
Closed -$1.74M
AABA
795
PUT
DELISTED
Altaba Inc
AABA
-30,000
Closed -$1.74M
BKS
796
CALL
DELISTED
Barnes & Noble
BKS
-200,000
Closed -$1.42M
BKS
797
DELISTED
Barnes & Noble
BKS
-789,340
Closed -$5.6M
UPL
798
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
-110,685
Closed -$85K
TVPT
799
DELISTED
Travelport Worldwide Limited
TVPT
-124,700
Closed -$1.95M
BEL
800
DELISTED
Belmond Ltd.
BEL
-163,400
Closed -$4.09M

Similar funds

Caption Management's Q1 2019 Portfolio in Review

As of Q1 2019, Caption Management held 823 positions worth $1.81B, up 45% from $1.25B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management deployed $409M of net new capital in Q1 2019, opening 371 new positions and adding to 67 existing holdings. Its largest new stake was Tapestry: 580,000 shares worth $18.8M.

By sector, the portfolio is most concentrated in Healthcare at 3.9% of assets, down from 4.5% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Somnigroup International, an estimated $4.33M trimmed.

  • Caption Management's largest Q1 2019 buy was Tapestry: 580,000 shares worth $18.8M.
  • Caption Management added most to Bristol-Myers Squibb in Q1 2019, an estimated $13.2M increase.
  • Caption Management's biggest Q1 2019 reduction was Somnigroup International, cutting an estimated $4.33M.
  • Caption Management fully exited Caesars Entertainment in Q1 2019, selling an estimated $29.9M.
  • Caption Management's ten largest holdings make up 16% of its $1.81B portfolio in Q1 2019.
  • Caption Management opened 371 new positions and closed 283 in Q1 2019.
  • Caption Management's portfolio value rose 45% quarter-over-quarter to $1.81B.

Based on Caption Management's 13F filing for Q1 2019, filed 14 May 2019.